Cornea

AZR-MD-001 ophthalmic ointment showed positive 3-month safety and efficacy results for the treatment of meibomian gland dysfunction, according to a press release from Azura Ophthalmics.

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses the IC-8 Apthera IOL from AcuFocus, designed to correct up to 1.5 D of astigmatism.

MONTEREY, Calif. — There is more than one way to treat neurotrophic keratopathy.

MILAN — At the ESCRS meeting, Efekan Çoşkunseven, MD, speaks about combined treatment in keratoconus.

MILAN — At the ESCRS meeting, Emilio Torres, MD, PhD, speaks about a novel OCT-based corneal elastography method implemented in a clinical prototype.

LAS VEGAS — Théa Pharma Inc. showcased AcellFX, an acellular amniotic membrane the company acquired from Akorn earlier this year, as well as its iVizia line of dry eye products, at Vision Expo West.

The FDA accepted a new drug application for NOV03, an investigational treatment for the signs and symptoms of dry eye disease, according to a press release from Bausch + Lomb and Novaliq.

AR-15512, a transient receptor potential melastatin 8 agonist, demonstrated significant improvement of dry eye disease signs, symptoms and related quality of life in a phase 2b study.

Proper protection from sunlight and ultraviolet rays is critical for eye health and vision, and the easiest and most effective way to achieve this is by wearing a good pair of sunglasses.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Dee Stephenson, MD, discusses Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device.